Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 6/28/2023
Free online continuing education course on the health effects of wildfire smoke
Designed for healthcare professionals to learn about the health effects of wildfire smoke and educate their patients on actions that can reduce exposure. - 6/26/2023
Daily low-dose ASA use in elderly patients increases the risk of anemia
Study finds an increase in anemia and a decline in ferritin in otherwise healthy older adults taking daily low-dose acetylsalicylic acid. - 6/25/2023
‘Almost constantly’: What’s the real effect of social media on youth mental health?
U.S. Surgeon General’s advisory highlights increasing concerns about social media’s effects on the mental health of children and adolescents. - 6/19/2023
New U.S. guidelines on the pharmacologic management of chronic idiopathic constipation
Provide a comprehensive outline of the various OTC and prescription agents available for the treatment of chronic idiopathic constipation in adults. - 6/12/2023
Drug news—May/June 2023
A review of new launches, new indications, new dosage forms and Health Canada advisories. - 6/12/2023
New resource to help explain medication ‘deprescribing’ to patients
JAMA patient information page answers common patient questions about deprescribing. - 6/7/2023
2023 update to Beers Criteria for potentially inappropriate medications in older adults
American Geriatrics Society provides an updated list of meds that are best avoided by older adults in most circumstances or in certain situations. - 6/6/2023
POP QUIZ: Type 2 diabetes remission
According to recent Diabetes Canada guidelines, remission of type 2 diabetes—defined as achieving an A1C in the nondiabetes range after stopping glucose-lowering medication(s)—is possible for some individuals. - 6/5/2023
Canadian influenza vaccine guidelines for 2023-24 are now available
NACI recommends offering influenza vaccine annually to anyone six months of age or older who does not have a contraindication to the vaccine. - 6/3/2023
Biosimilars are equivalent to reference biologics in rheumatoid arthritis
Systematic review and meta-analysis finds that patients using biosimilars have equivalent clinical responses and functional capacity compared with those using reference biologic drugs.
